741728
Last Update Posted: 2025-02-10
Recruiting has ended
All Genders accepted | 50 Years-75 Years |
10157 Estimated Participants | No Expanded Access |
Observational Study | Accepts healthy volunteers |
Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population
The aim of the present Paris Prospective Study III (PPS3) is (1) to assess the determinants of the regulation of heart rate and blood pressure variations and carotid properties (under different physiologic stimulations) and (2) to evaluate the respective contribution of heart rate, blood pressure variations and carotid properties to cardiovascular morbidity and mortality including sudden death during 10 years at least in healthy considered subjects.
Overall, 10 157 men and women have been recruited during May 2008 and June 2012 for an extensive clinical examination including a 2h holter electrocardiography (ECG), a carotid doppler echo tracking, a step test, as well as blood and DNA collections. Since then, the cardiovascular morbidity and mortality of the participants is being followed up for 10 years at least and will continue up to 2032.
Eligibility
Relevant conditions:
Community Based Study
Cardiovascular Disease
Sudden Death
Blood Pressure
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Contact Information
Overall Contact
Xavier Jouven, MD, PhD
xavier.jouven@egp.aphp.fr
1 56 09 36 87
Jean-Philippe Empana, MD, PhD
jean-philippe.empana@inserm.fr
1 53 98 80 20
Data sourced from ClinicalTrials.gov